ReceptoPharm  
Home   Drug Development   CRO Services   Newsroom   About ReceptoPharm   Contact
» Overview
» Research Platform
» R&D Pipeline
» Published Research
» Licensing
 
Drug Development

ReceptoPharm is developing proprietary therapeutic protein products for the treatment of neurological, viral and and autoimmune disorders.

» Learn More
 
CRO Services

ReceptoPharm offers a full range of contract research services catering to small and start-up biotech companies.

» Learn More

Licensing

As ReceptoPharm continues to complete the clinical Phases, the Company expects to engage in licensing discussions to assist in final product development and market entry.

For more information about ReceptoPharm or to discuss licensing opportunities, please contact us.

Recent News
February 02, 2010
Nutra Pharma Announces Fourth Quarter Sales for its Over-the-Counter (OTC) Pain Reliever, Cobroxin
 
E-Alerts
Signup to receive news and announcements from ReceptoPharm and Nutra Pharma:
First Name:
Last Name:
Email:
NPC